Partner With Us
After decades of unfulfilled potential, the commercial reality of gene therapies are beginning to take shape. However, the leading drug developer organizations in this field are telling us that they have little visibility of which contract service providers have the technical experience, capacity and flexibility to meet their demands.
Senior decision makers at these leading companies will come together in April 2018 at Gene Therapy for Rare Disorders 2018, actively seeking to collaborate with organizations that can help them accelerate their gene therapy development.
Our inaugural conference back in April 2017 attracted a very senior audience – 29% of attendees were C-Level and a further 20% VP-Level – demonstrating the quality of audience that you would be able to engage with.
If you have capabilities that would benefit our audience in the gene therapy space, Gene Therapy for Rare Disorders 2018 provides a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.
Act now to stay ahead of the curve and seize the wealth of opportunity on offer.